Top 10 Companies in the (S)-4-Methyl-1-phenylethylamine (CAS 27298-98-2) Market (2026): Market Leaders Powering Global Chemistry

MARKET INSIGHTS

Global (S)-4-Methyl-1-phenylethylamine (CAS 27298-98-2) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 7.3% during the forecast period.

(S)-4-Methyl-1-phenylethylamine (CAS 27298-98-2) is a chiral primary amine and an enantiomerically pure compound belonging to the phenylethylamine family. Characterized by its (S)-configuration at the stereocenter, this compound serves as a valuable chiral building block and resolving agent in asymmetric synthesis. Its high optical purity and well-defined stereochemistry make it particularly significant in the synthesis of pharmaceutically active compounds, agrochemicals, and fine chemicals where stereoselectivity is critical.

The market is witnessing steady growth driven by rising demand for chiral intermediates in pharmaceutical manufacturing and the increasing adoption of asymmetric synthesis methodologies across the specialty chemicals sector. Furthermore, growing investments in drug discovery pipelines and the expanding need for enantiomerically pure compounds in active pharmaceutical ingredient (API) production continue to broaden the compound’s application scope. Key suppliers operating in this market include Sigma‑Aldrich (Merck KGaA), TCI Chemicals, and Alfa Aesar, among other specialty chemical manufacturers with established chiral chemistry portfolios.

(S)-4-Methyl-1-phenylethylamine (CAS 27298-98-2) Market – View in Detailed Research Report

---

Top 10 Companies in the (S)-4-Methyl-1-phenylethylamine (CAS 27298-98-2) Market (2026)

10️⃣ 1. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Pharmaceutical Grade (S)-4-Methyl-1-phenylethylamine, advanced chiral synthesis services

Merck KGaA is a global leader in specialty chemicals and pharmaceuticals, providing high‑purity chiral intermediates that meet stringent regulatory standards. Their robust R&D capabilities ensure consistent enantiomeric excess and scalable production.

Sustainability & Growth Initiatives:

• Investment in green chemistry processes for chiral resolution
• Partnerships with CDMOs to accelerate API development
• Commitment to reducing carbon footprint in manufacturing

9️⃣ 2. Sigma‑Aldrich (Merck)

Headquarters: Burlington, USA
Key Offering: Research & Development Grade chiral amines, custom synthesis

Sigma‑Aldrich supplies a wide range of high‑purity chiral reagents, supporting academic and industrial research in asymmetric synthesis.

Sustainability & Growth Initiatives:

• Eco‑friendly packaging solutions
• Development of biocatalytic resolution methods
• Expansion of global distribution network

8️⃣ 3. Tokyo Chemical Industry Co., Ltd. (TCI)

Headquarters: Tokyo, Japan
Key Offering: High‑purity chiral amines, advanced catalytic processes

TCI delivers premium chiral building blocks with a focus on scalable synthesis and strict quality control.

Sustainability & Growth Initiatives:

• Implementation of continuous flow chemistry
• Partnerships with pharmaceutical companies for API development
• Investment in renewable energy for production facilities

7️⃣ 4. Thermo Fisher Scientific (Alfa Aesar)

Headquarters: Boston, USA
Key Offering: Technical Grade chiral amines, catalog and custom synthesis

Alfa Aesar provides reliable chiral reagents for research and industrial applications, backed by a strong distribution network.

Sustainability & Growth Initiatives:

• Reduction of hazardous waste in synthesis
• Development of greener solvent systems
• Enhanced digital supply chain transparency

6️⃣ 5. Enamine Ltd.

Headquarters: Kyiv, Ukraine
Key Offering: Custom synthesis of enantiomerically pure amines, process development

Enamine offers flexible synthesis solutions tailored to the needs of drug discovery and fine chemical production.

Sustainability & Growth Initiatives:

• Adoption of biocatalytic routes for chiral amines
• Collaboration with CDMOs for scale‑up
• Focus on energy‑efficient processes

5️⃣ 6. Biosynth Carbosynth

Headquarters: Uster, Switzerland
Key Offering: High‑purity chiral amines, rapid custom synthesis

Biosynth Carbosynth delivers high‑quality chiral intermediates with fast turnaround times for research and industrial clients.

Sustainability & Growth Initiatives:

• Optimization of solvent usage
• Implementation of waste minimization protocols
• Support for green chemistry research projects

4️⃣ 7. Apollo Scientific Ltd.

Headquarters: London, UK
Key Offering: GMP‑grade chiral amines, custom synthesis services

Apollo Scientific specializes in delivering regulatory‑compliant chiral intermediates for pharmaceutical manufacturers.

Sustainability & Growth Initiatives:

• Development of greener catalytic processes
• Partnerships with academic institutions for sustainable chemistry
• Expansion of global production capacity

3️⃣ 8. Combi-Blocks Inc.

Headquarters: Chicago, USA
Key Offering: Modular synthesis platforms, chiral building blocks

Combi-Blocks provides modular solutions that enable rapid synthesis of chiral compounds with high purity.

Sustainability & Growth Initiatives:

• Use of renewable feedstocks in synthesis
• Development of scalable, low‑energy processes
• Engagement in circular economy initiatives

2️⃣ 9. Oakwood Chemical

Headquarters: Houston, USA
Key Offering: Technical and reagent grade chiral amines, custom synthesis

Oakwood Chemical delivers reliable chiral reagents for research and industrial applications, with a focus on quality and compliance.

Sustainability & Growth Initiatives:

• Implementation of greener production techniques
• Collaboration with CDMOs for efficient scale‑up
• Commitment to reducing environmental impact

1️⃣ 10. Santa Cruz Biotechnology

Headquarters: Santa Cruz, USA
Key Offering: Research grade chiral amines, academic supply services

Santa Cruz Biotechnology supplies high‑quality chiral reagents to the academic community, supporting cutting‑edge research.

Sustainability & Growth Initiatives:

• Use of sustainable sourcing for raw materials
• Development of eco‑friendly synthesis protocols
• Support for green chemistry education programs

---

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/307867/methylphenylethylamine-market

Get Full Report: https://www.24chemicalresearch.com/reports/307867/methylphenylethylamine-market

---

Market Outlook (2026‑2034)

With a projected CAGR of 7.3% from 2026 to 2034, the (S)-4‑Methyl‑1‑phenylethylamine market is poised for robust growth. Key drivers include the expanding pipeline of chiral pharmaceuticals, increasing adoption of asymmetric synthesis, and growing demand for enantiomerically pure agrochemicals. The Asia‑Pacific region is expected to lead volume growth, while North America remains the most advanced market in terms of technology adoption and regulatory compliance.

Future Trends

Emerging trends that will shape the market include:

• Advances in biocatalytic resolution methods that reduce reliance on stoichiometric resolving agents.
• Integration of continuous flow and automation in chiral synthesis to improve scalability and reduce waste.
• Expansion of chiral amines into advanced materials such as chiral ionic liquids and liquid crystal technologies.
• Increased focus on sustainability, with manufacturers adopting greener solvents, renewable feedstocks, and energy‑efficient processes.